recombinant human stem cell factor (Shanghai Wanxing Bio-Pharmaceutical/Second Military Medical University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant human stem cell factor (Shanghai Wanxing Bio-Pharmaceutical/Second Military Medical University)
Drug Alias NamerhSCF (Shanghai Wanxing Bio-Pharmaceutical/Second Military Medical University)
ClassificationBiologics > Protein drugs > Recombinant proteinCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionHaematopoiesis stimulants
TargetsUpdating
Therapy Area/IndicationsAnemia, Aplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Wanxing Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSecond Military Medical University Of Chinese People'S Liberation ArmyShanghai Wanxing Biological Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAnemia, Aplastic

Other Information

ATC CodeN/A
Related LinksN/A